A041960 Stock Overview
Manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Komipharm International Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,930.00 |
| 52 Week High | ₩4,940.00 |
| 52 Week Low | ₩3,610.00 |
| Beta | -0.67 |
| 1 Month Change | 0.90% |
| 3 Month Change | -9.66% |
| 1 Year Change | -7.53% |
| 3 Year Change | -51.72% |
| 5 Year Change | -68.43% |
| Change since IPO | 289.60% |
Recent News & Updates
Impressive Earnings May Not Tell The Whole Story For Komipharm International (KOSDAQ:041960)
Nov 08
Is Komipharm International (KOSDAQ:041960) A Risky Investment?
Mar 27Recent updates
Impressive Earnings May Not Tell The Whole Story For Komipharm International (KOSDAQ:041960)
Nov 08Is Komipharm International (KOSDAQ:041960) A Risky Investment?
Mar 27A Look At Komipharm International's (KOSDAQ:041960) Share Price Returns
Feb 26Is Komipharm International Co., Ltd.'s (KOSDAQ:041960) Shareholder Ownership Skewed Towards Insiders?
Jan 22
Komipharm International (KOSDAQ:041960) Is Carrying A Fair Bit Of Debt
Dec 18Shareholder Returns
| A041960 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.1% | 6.8% | 0.2% |
| 1Y | -7.5% | 17.8% | -4.9% |
Return vs Industry: A041960 underperformed the KR Pharmaceuticals industry which returned 12.4% over the past year.
Return vs Market: A041960 underperformed the KR Market which returned -5.4% over the past year.
Price Volatility
| A041960 volatility | |
|---|---|
| A041960 Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in KR Market | 13.0% |
| 10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A041960 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A041960's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 158 | Seong-Cheol Moon | www.komipharm.co.kr |
Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. The company manufactures veterinary drugs in injectable, powder, oral solution, topical solution, disinfectant, and other forms. It is also developing anticancer drugs and cancer pain-relieving agents for human health and life.
Komipharm International Co., Ltd. Fundamentals Summary
| A041960 fundamental statistics | |
|---|---|
| Market cap | ₩272.26b |
| Earnings (TTM) | ₩11.34b |
| Revenue (TTM) | ₩54.53b |
24.0x
P/E Ratio5.0x
P/S RatioIs A041960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A041960 income statement (TTM) | |
|---|---|
| Revenue | ₩54.53b |
| Cost of Revenue | ₩35.22b |
| Gross Profit | ₩19.31b |
| Other Expenses | ₩7.97b |
| Earnings | ₩11.34b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 163.68 |
| Gross Margin | 35.41% |
| Net Profit Margin | 20.79% |
| Debt/Equity Ratio | 61.1% |
How did A041960 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 05:05 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Komipharm International Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.